Patent ID: 11884649
Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Field: Organic fine chemistry (Chemistry)
Classification: CPC C | IPC C

Claim 14:
15. A method of treating a disease in a subject in need thereof, said method comprising administering to the subject in need thereof an effective amount of a compound of claim 1, wherein the disease is Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, Mature Onset diabetes of the Young (MODY), Mutant INS-gene-induced Diabetes of the young (MIDY), Immune Checkpoint-induced Diabetes Mellitus, Wolfram's Syndrome, Wolcott-Rallison Syndrome, Idiopathic Pulmonary fibrosis (IPF), Familial Pulmonary Fibrosis (FPF), Asthma, Alzheimer's disease, Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Chronic traumatic encephalopathy, Cystic fibrosis, cytochrome c oxidase deficiency, degenerative Leigh syndrome, Ehlers-Danlos syndrome, Fibrodysplasia ossificans progressiva, Friedreich's ataxia, Frontotemporal dementia, cardiovascular diseases, coronary artery disease, aortic stenosis, Huntington's disease, Infantile neuroaxonal dystrophy, Keratoconus, Keratoglobus, Leukodystrophies, Wet Macular degeneration, Dry Macular degeneration, Marfan's syndrome, mitochondrial myopathies, Mitochondrial DNA depletion syndrome, Multiple sclerosis, Multiple system atrophy, Muscular dystrophies, Neuronal ceroid lipofuscinosis, Niemann-Pick diseases, Osteoarthritis, Osteoporosis, Parkinson's disease, Pulmonary arterial hypertension, prion disease, Creutzfeldt-Jakob disease, fatal familial insomnia, Progressive supranuclear palsy, Retinitis pigmentosa, Rheumatoid arthritis, Sandhoff Disease, Scleroderma, Spinal muscular atrophy, Subacute sclerosing panencephalitis, Tay-Sachs disease, Vascular dementia, or cancer.